FLGT
Fulgent Genetics Inc
21.50$
-0.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -344.1% | -10.1% | 24.1% | 7.1% | -3.2% | 17.0% | 33.3% | 54.3% | 41.0% | 9.3% | 7.4% | -31.5% | |
| 15.3% | 6.0% | 6.4% | 9.2% | 10.1% | 7.7% | 0.7% | 1.1% | 5.3% | 9.0% | 8.8% | 7.5% | |
| – | 85.2% | 25.5% | 11.3% | 10.8% | 9.9% | 1.9% | 1.6% | 5.3% | 14.8% | 15.7% | 12.3% | |
| 1.0% | 89.0% | 57.1% | 15.1% | 17.4% | 13.0% | 2.1% | 2.3% | 12.2% | – | – | – | |
| -25.3% | -18.3% | -10.2% | -3.8% | -5.8% | -2.8% | -21.7% | -0.3% | 0.3% | 1.0% | -2.6% | -36.5% | |
| 57.2% | 21.9% | 20.7% | 28.6% | 13.3% | 3.6% | 8.7% | 2.4% | 3.0% | 7.7% | 14.2% | 7.0% | |
| -61.0% | -23.0% | -234.2% | -10.9% | 4.4% | -89.3% | -77.4% | -55.1% | -42.2% | 13.4% | -20.6% | 34.5% | |
| 359.3% | 48.0% | 25.1% | 0.0% | – | – | 3.6% | 0.4% | – | – | – | – | |
| 2,878.7% | 384.2% | -36.0% | 0.2% | 0.1% | -0.1% | 0.0% | -0.4% | -12.3% | -9.6% | -1.1% | -4.3% | |
| – | – | – | 80.2% | 70.3% | 46.2% | 3.6% | 0.0% | -0.2% | -6.9% | -0.6% | -0.3% | |
| 313.0% | 36.5% | 250.5% | -4.1% | 0.1% | 88.5% | 62.0% | 8.6% | -12.5% | -16.5% | -1.7% | -4.6% | |
| -92.1% | 3.4% | 40.5% | -7.5% | 1.2% | 16.1% | 17.9% | 7.8% | -13.8% | 6.2% | -14.9% | -1.5% | |
| -401.3% | -32.0% | 3.4% | -21.5% | -16.4% | 13.3% | 24.7% | 51.9% | 37.9% | 1.7% | -6.8% | -38.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.